Skip to main content
uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
6.59
+0.30 (4.77%)
Dec 5, 2024, 4:00 PM EST - Market closed

uniQure Revenue

uniQure had revenue of $2.29M in the quarter ending September 30, 2024, with 62.54% growth. This brings the company's revenue in the last twelve months to $28.59M, down -74.45% year-over-year. In the year 2023, uniQure had annual revenue of $15.84M, down -85.12%.

Revenue (ttm)
$28.59M
Revenue Growth
-74.45%
P/S Ratio
11.15
Revenue / Employee
$59,556
Employees
480
Market Cap
321.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.84M-90.64M-85.12%
Dec 31, 2022106.48M-417.52M-79.68%
Dec 31, 2021524.00M486.49M1,296.82%
Dec 31, 202037.51M30.23M415.23%
Dec 31, 20197.28M-4.00M-35.48%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sanara MedTech 78.06M
AC Immune 48.51M
iTeos Therapeutics 35.00M
Eton Pharmaceuticals 34.68M
Nyxoah 5.67M
Artiva Biotherapeutics 2.60M
Immutep 2.56M
Q32 Bio -14.66M
Revenue Rankings

QURE News

More News